Fig. 1
From: Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer
Expression of the INHBA/follistatin (FST) axis is altered in human breast cancers. Relative (a) INHBA and (b) FST expression in normal breast versus breast cancer using publicly available datasets from The Cancer Genome Atlas (TCGA). c Relative FST expression in normal breast stroma versus breast cancer stroma in the Finak et al. dataset. d Western blot analysis of FST protein expression in immortalized, nontransformed mammary epithelial cells (NT) and breast cancer cell lines representing luminal, human epidermal growth factor receptor 2-positive (HER2+), and triple-negative breast cancer (TNBC) subtypes